Advertisement
"We are very pleased to welcome Mr. Hsu to our team," said Mr. Xu Hang,Mindray's chairman and co-chief executive officer. "Mr. Hsu brings valuableU.S. market experience and has executed strategies accelerating growth in highpotential markets around the world. I am confident his extensive backgroundin the medical device industry will allow him to make an immediate impact onour growth in North America."
Advertisement
"We view the U.S. market as strategically important in the long term,"added Mr. Li Xiting, Mindray's president and co-chief executive officer. "Withour expanding R&D and sales and marketing operations in Seattle, and with 11products having received FDA 510(k) clearance, and up to 5 more expected to beapproved in 2008, we are fully committed to continuing our investment in theU.S. We are excited to add Mr. Hsu's tremendous experience to our seniormanagement team as we continue to grow our international business."
Mr. Hsu brings more than 25 years of experience in medical device salesand marketing as well as strategic management. Mr. Hsu will be responsiblefor sales, marketing and services of our products in North America markets.Prior to joining Mindray, Mr. Hsu was managing director of SonoSite in NorthAsia and prior to that he was senior director of global strategic marketdevelopment of cardiac and monitoring systems for Philips Medical Systems inAndover, Massachusetts. Previously, he also served as senior director of AsiaPacific for Philips Medical Systems' ultrasound business line and as vicepresident and general manager of Asia Pacific for Hewlett Packard's MedicalProducts Group. Mr. Hsu holds bachelor's degrees in Electronics Engineeringand Electrical Engineering from National Taiwan Institute of Technology.
About Mindray
Mindray Medical International Limited is a leading developer, manufacturerand marketer of medical devices in China with a significant and growingpresence worldwide. Established in 1991, Mindray offers a broad range ofproducts across three primary business segments: patient monitoring devices,diagnostic laboratory instruments, and ultrasound imaging systems. Mindray isheadquartered in Shenzhen, China, and has 29 local sales and service officesin China, as well as sales and service offices in Amsterdam, Boston, Istanbul,London, Mexico City, Mumbai, Sao Paulo, Seattle, Toronto and Vancouver. Formore information, please visit http://www.mindray.com .
Safe Harbor Statement
This announcement contains forward-looking statements. These statementsare made under the ''safe harbor'' provisions of the U.S. Private SecuritiesLitigation Reform Act of 1995. These forward-looking statements can beidentified by terminology such as "will," "expects," "anticipates," "future,""intends," "plans," "believes," "estimates," "confident" and similarstatements. Statements that are not historical facts, including statementsabout Mindray's beliefs and expectations, are forward-looking statements.Forward-looking statements involve inherent risks and uncertainties.Information regarding these risks and uncertainties is included in our publicfilings with the Securities and Exchange Commission. All information providedin this press release is as of January 2, 2008, and Mindray undertakes no dutyto update such information, except as required under applicable law.For investor and media inquiries, please contact: In China: Investor Relations Mindray Medical International Limited Tel: +86-755-2658-2518 Email: [email protected] Justin Knapp Ogilvy Public Relations Worldwide, Beijing
